How much does a box of furmonertinib cost and analysis of price differences in different regions

Furmonertinib (Furmonertinib) is a domestic third-generation EGFR tyrosine kinase inhibitor (< span>TKI), mainly used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC). The drug was approved for marketing by the National Medical Products Administration (NMPA) in 2021 and passed national medical insurance negotiations in the same year, significantly reducing the cost of medication for patients.

In China, the medical insurance price of fumetinib is 2494 yuan per box (40mg×28 tablets), based on one tablet per day Calculated, the average monthly cost is about 747 yuan, and the medical insurance reimbursement ratio can reach 50% to 70%. The specific ratio depends on the region and the patient's medical insurance type. After reimbursement from medical insurance, the patient's out-of-pocket expenses range from 747 yuan to 1,247 yuan per month.

The market price of fumetinib may vary in different regions. For example, in some areas, patients may need to pay the full price, which is RMB 16,000 per box. Therefore, patients should consult their local hospital or pharmacy to learn about specific prices and medical insurance reimbursement when purchasing.

In general, fumetinib, as a domestic innovative drug, has significant efficacy in the treatment of EGFR mutation-positive non-small cell lung cancer. Through the support of national medical insurance, patients' medication burden has been effectively reduced. However, the specific cost is still affected by factors such as region, medical insurance policy, and purchasing channels. Patients should choose the appropriate purchasing method based on their own circumstances.

Reference materials:https://www.drugs.com/